Xiaofeng Zhu

Professor

Case Western Reserve University
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (11)

Year:

2025

Multivariable cis-Mendelian randomization (cis-MVMR) has become an effective approach for identifying therapeutic targets that influence disease susceptibility. However, biases from invalid instruments, such as weak instruments and horizontal pleiotropy, remain unsolved. In this paper, we propose a new method called the cis-Mendelian randomization bias correction estimating equation (cis-MRBEE), which mitigates weak instrument bias by leveraging a local sparse genetic architecture: most variants within a genomic region are associated with a trait through linkage disequilibrium with a few causal variants. Cis-MRBEE identifies causal variants or proxies of exposures via fine-mapping, re-estimates genetic associations using the identified variants, and applies a double-penalized minimization to estimate causal exposures and account for horizontal pleiotropic effects. Simulations showed that in the presence of weak instruments and horizontal pleiotropy, directly adapting standard MVMR methods to cis-MVMR was infeasible, and existing cis-MVMR methods failed to control type I errors. In contrast, cis-MRBEE exhibited robustness to these sources of bias. We applied cis-MRBEE to the ANGPTL3 locus and identified a credible set comprising APOA1, APOC1, and PCSK9 as likely causal proteins for LDL-C, HDL-C, and TG. The subsequent analysis revealed a complex protein regulation network that influenced lipid traits. Furthermore, we used cis-MRBEE to discover that the expressions of CR1 in the basal ganglia, hippocampus, and oligodendrocytes were potentially causal for Alzheimer’s disease and its biomarkers, A$\beta $42 and pTau, in cerebrospinal fluid.

Year:

2025

Multivariable Mendelian randomization (MVMR) has been largely limited to individuals of European ancestry, due to the larger sample sizes available in European genome-wide association studies (GWAS). We introduce MRBEE-TL, one of the first multi-ancestry MVMR methods, which combines transfer learning with bias-corrected estimating equations to improve power in underpowered ancestries and to assess cross-ancestry heterogeneity of disease risk factors. In simulations, MRBEE-TL consistently outperformed MR methods that relied solely on ancestry-specific GWAS data. In real data analyses, MRBEE-TL not only identified ancestry-consistent and ancestry-specific causal effects missed by conventional methods, but also improved power in African and East Asian ancestries. MRBEE-TL is available through the R package MRBEEX at https://github.com/harryyiheyang/MRBEEX .

Year:

2025

There is a long-standing debate about the magnitude of the contribution of gene-environment interactions to phenotypic variations of complex traits owing to the low statistical power and few reported interactions to date. To address this issue, the Gene-Lifestyle Interactions Working Group within the Cohorts for Heart and Aging Research in Genetic Epidemiology Consortium has been spearheading efforts to investigate G × E in large and diverse samples through meta-analysis. Here, we present a powerful new approach to screen for interactions across the genome, an approach that shares substantial similarity to the Mendelian randomization framework. We identify and confirm 5 loci (6 independent signals) interacted with either cigarette smoking or alcohol consumption for serum lipids, and empirically demonstrate that interaction and mediation are the major contributors to genetic effect size heterogeneity across populations. The estimated lower bound of the interaction and environmentally mediated heritability is significant ( P < 0.02) for low-density lipoprotein cholesterol and triglycerides in Cross-Population data. Our study improves the understanding of the genetic architecture and environmental contributions to complex traits.

Year:

2024

Motivation Nearly two decades of genome-wide association studies (GWAS) have identify thousands of disease-associated genetic variants, but very few genes with evidence of causality. Recent methodological advances demonstrate that Mendelian randomization (MR) using expression quantitative loci (eQTLs) as instrumental variables can detect potential causal genes. However, existing MR approaches are not well suited to handle the complexity of eQTL GWAS data structure and so they are subject to bias, inflation, and incorrect inference. Results We present a whole-genome regulatory network analysis tool (HORNET), which is a comprehensive set of statistical and computational tools to perform genome-wide searches for causal genes using summary level GWAS data, i.e. robust to biases from multiple sources. Applying HORNET to schizophrenia, eQTL effects in the cerebellum were spread throughout the genome, and in the cortex were more localized to select loci. Availability and implementation Freely available at https://github.com/noahlorinczcomi/HORNET or Mac, Windows, and Linux users.

Year:

2024

A genetic Gaussian network of multiple phenotypes, constructed through the inverse matrix of the genetic correlation matrix, is informative for understanding the biological dependencies of the phenotypes. However, its estimation may be challenging because the genetic correlation estimates are biased due to estimation errors and idiosyncratic pleiotropy inherent in GWAS summary statistics. Here, we introduce a novel approach called estimation of genetic graph (EGG), which eliminates the estimation error bias and idiosyncratic pleiotropy bias with the same techniques used in multivariable Mendelian randomization. The genetic network estimated by EGG can be interpreted as shared common biological contributions between phenotypes, conditional on others. We use both simulations and real data to demonstrate the superior efficacy of our novel method in comparison with the traditional network estimators.

Year:

2024

Mendelian randomization (MR) has become a popular tool for inferring causality of risk factors on disease. There are currently over 45 different methods available to perform MR, reflecting this extremely active research area. It would be desirable to have a standard simulation environment to objectively evaluate the existing and future methods. We present simmrd , an open‐source software for performing simulations to evaluate the performance of MR methods in a range of scenarios encountered in practice. Researchers can directly modify the simmrd source code so that the research community may arrive at a widely accepted framework for researchers to evaluate the performance of different MR methods.

Year:

2024

Transcriptome-wide association studies (TWAS) are commonly used to prioritize causal genes underlying associations found in genome-wide association studies (GWAS) and have been extended to identify causal genes through multivariable TWAS methods. However, recent studies have shown that widespread infinitesimal effects due to polygenicity can impair the performance of these methods. In this report, we introduce a multivariable TWAS method named Tissue-Gene pairs, direct causal Variants, and Infinitesimal effects selector (TGVIS) to identify tissue-specific causal genes and direct causal variants while accounting for infinitesimal effects. In simulations, TGVIS maintains an accurate prioritization of causal gene-tissue pairs and variants and demonstrates comparable or superior power to existing approaches, regardless of the presence of infinitesimal effects. In the real data analysis of GWAS summary data of 45 cardiometabolic traits and expression/splicing quantitative trait loci (eQTL/sQTL) from 31 tissues, TGVIS improves causal gene prioritization and enhances the biological interpretability over existing methods.

Year:

2024

Obstructive sleep apnea (OSA) is a multifactorial sleep disorder characterized by a strong genetic basis. Excessive daytime sleepiness (EDS) is a symptom that is reported by a subset of OSA patients, persisting even after treatment with continuous positive airway pressure (CPAP). It is recognized as a clinical subtype underlying OSA carrying alarming heightened cardiovascular risk. Thus, conceptualizing EDS as an exposure variable, we sought to investigate EDS’s influence on genetic variation linked to apnea-hypopnea index (AHI), a diagnostic measure of OSA severity. This study serves as the first large-scale genome-wide gene x environment interaction analysis for AHI, investigating the interplay between its genetic markers and EDS across and within specific sex. Our work pools together whole genome sequencing data from seven cohorts, enabling a diverse dataset (four population backgrounds) of over 11,500 samples. Among the total 16 discovered genetic targets with interaction evidence with EDS, eight are previously unreported for OSA, including CCDC3 , MARCHF1 , and MED31 identified in all sexes; TMEM26 , CPSF4L , and PI4K2B identified in males; and RAP1GAP and YY1 identified in females. We discuss connections to insulin resistance, thiamine deficiency, and resveratrol use that may be worthy of therapeutic consideration for excessively sleepy OSA patients.

Year:

2024

Motivation Nearly two decades of genome-wide association studies (GWAS) have identify thousands of disease-associated genetic variants, but very few genes with evidence of causality. Recent methodological advances demonstrate that Mendelian Randomization (MR) using expression quantitative loci (eQTLs) as instrumental variables can detect potential causal genes. However, existing MR approaches are not well suited to handle the complexity of eQTL GWAS data structure and so they are subject to bias, inflation, and incorrect inference. Results We present a whole-genome regulatory network analysis tool (HORNET), which is a comprehensive set of statistical and computational tools to perform genome-wide searches for causal genes using summary level GWAS data that is robust to biases from multiple sources. Applying HORNET to schizophrenia, we identified differential magnitudes of gene expression causality. Applying HORNET to schizophrenia, we identified differential magnitudes of gene expression causality across different brain tissues. Availability and Implementation Freely available at https://github.com/noahlorinczcomi/HORNETor Mac, Windows, and Linux users. Contact [email protected] .

Year:

2024

Year:

2024

Collaborators (44)

Harold Snieder

Scientific Staff

University Medical Center Groningen

NETHERLANDS
View details

Amy Bentley

National Human Genome Research Institute

UNITED STATES
View details

Cristina Menni

King’s College London

UNITED KINGDOM
View details

Nicholas Wareham

Director

University of Cambridge

UNITED KINGDOM
View details

Joseph McCormick

James H. Steele Professor

-

UNITED STATES
View details

Laura Raffield

Assistant Professor

University of North Carolina at Chapel Hill

UNITED STATES
View details

Han Chen

Professor

NYU School of Medicine

UNITED STATES
View details

Vilmundur Gudnason

Professor

University of Iceland

ICELAND
View details

Bertha Hidalgo

Associate Professor and Associate Dean

University of Alabama, Tuscaloosa

UNITED STATES
View details

Simon R. Cox

Personal Chair of Brain and Cognitive Ageing

University of Edinburgh

UNITED KINGDOM
View details

Jennifer Ann Smith

Professor

University of Michigan

UNITED STATES
View details

Sarah Harris

University of Edinburgh

UNITED KINGDOM
View details

William Bush

Professor

Case Western Reserve University

UNITED STATES
View details

Ching-Ti Liu

Boston University

UNITED STATES
View details

Ko Willems van Dijk

Professor

Leiden University Medical Center

NETHERLANDS
View details

massimo mangino

Honorary Senior Lecturer

King’s College London

UNITED KINGDOM
View details

Heming Wang

Assistant Professor

Brigham and Women's Hospital

UNITED STATES
View details

Ilja Nolte

Senior Researcher of Statistical Genetics and Genetic Epidemiology

University Medical Center Groningen

NETHERLANDS
View details

Heather M Highland

University of North Carolina at Chapel Hill

UNITED STATES
View details

Marcus Dörr

University Medicine Greifswald

GERMANY
View details

Paul de Vries

Assistant Professor

The University of Texas Health Science Center at Houston School of Public Health

UNITED STATES
View details

Lisa de las Fuentes

Professor of Medicine and Biostatistics

Washington University School of Medicine

UNITED STATES
View details

Iris M. Heid

University of Regensburg

GERMANY
View details

Rodney Scott

Prof. of Medical Genetics

University of Newcastle Australia

AUSTRALIA
View details

Myriam Fornage

-

UNITED STATES
View details

Changwei Li

Associate Professor

University of Texas Southwestern Medical Center

UNITED STATES
View details

Mary Feitosa

Associate Professor

Washington University School of Medicine

UNITED STATES
View details

Debbie A Lawlor

Academic , Professor of Epidemiology, MRC Investigator and BHF Chair

University of Bristol

UNITED KINGDOM
View details

Sami Heikkinen

Research Director

University of Eastern Finland

FINLAND
View details

Peter Y Liu

University of California

UNITED STATES
View details

Charles Rotimi

Chief and Director

National Institutes of Health

UNITED STATES
View details

Kari North

Professor

University of North Carolina at Chapel Hill

UNITED STATES
View details

Kisung Nam

Seoul National University

SOUTH KOREA
View details

Michael Province

Professor, Head Division of Statistical Genomics

Washington University in St. Louis

UNITED STATES
View details

Uwe Völker

Professor, Head of Department

Universitätsmedizin Greifswald

GERMANY
View details

Quan Sun

Research Assistant Professor

University of Pennsylvania

UNITED STATES
View details

John Attia

University of Newcastle Australia

AUSTRALIA
View details

Nicholette Allred

Wake Forest Baptist Medical Center

UNITED STATES
View details

Mariaelisa Graff

Assistant Professor

University of North Carolina

UNITED STATES
View details

Albert Vernon Smith

University of Michigan

UNITED STATES
View details

Brian Cade

Investigator

Brigham and Women's Hospital

UNITED STATES
View details

Terho Lehtimäki

University of Tampere

FINLAND
View details

SINA A. GHARIB

University of Washington

UNITED STATES
View details

Jian'an Luan

University of Cambridge

UNITED KINGDOM
View details